Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in Virus Res Retrieve available abstracts of 45 articles: HTML format

Single Articles

March 2024
1. CHOWDHURY IR, Viktorova E, Samal SK, Belov GA, et al
   The effect of 5' and 3' non-translated regions on the expression of a transgene from a Newcastle disease virus vector.
   Virus Res. 2024;341:199309.
   PubMed     Abstract available
   
   
   January 2024
2. ZAHEDIPOUR F, Zahedipour F, Zamani P, Jaafari MR, et al
   Harnessing CRISPR Technology for Viral Therapeutics and Vaccines: From Preclinical Studies to Clinical Applications.
   Virus Res. 2024 Jan 9:199314. doi: 10.1016/j.virusres.2024.199314.
   PubMed     Abstract available
   
   
   
3. DESMET C, Coelho-Cruz B, Mehn D, Colpo P, et al
   ASFV epitope mapping by high density peptides microarrays.
   Virus Res. 2024;339:199287.
   PubMed     Abstract available
   
   
   December 2023
4. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
   Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
   Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
   PubMed     Abstract available
   
   
   November 2023
5. HASSAN MSH, Ali A, Mahmoud ME, Altakrouni D, et al
   Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine.
   Virus Res. 2023 Nov 21:199281. doi: 10.1016/j.virusres.2023.199281.
   PubMed     Abstract available
   
   
   August 2023
6. KO MK, Kim HW, Park SH, Park JH, et al
   The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
   Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
   PubMed     Abstract available
   
   
   July 2023
7. GUO Q, Zhu S, Wang D, Li X, et al
   Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China.
   Virus Res. 2023;334:199177.
   PubMed     Abstract available
   
   
   
8. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
   Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
   Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
   PubMed     Abstract available
   
   
   
9. GOLDEN JW, Fitzpatrick CJ, Suschak JJ, Clements TL, et al
   Induced protection from a CCHFV-M DNA vaccine requires CD8(+) T cells.
   Virus Res. 2023 Jul 15:199173. doi: 10.1016/j.virusres.2023.199173.
   PubMed     Abstract available
   
   
   
10. SUN YY, Liu KS, Yun T, Ni Z, et al
    High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization.
    Virus Res. 2023;331:199111.
    PubMed     Abstract available
    
    
    June 2023
11. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    PubMed     Abstract available
    
    
    
12. LIU R, Lv Y, Sun W, Li M, et al
    Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
    Virus Res. 2023;334:199149.
    PubMed     Abstract available
    
    
    
13. SONG Y, Zhao Z, Liu L, Li Y, et al
    Knob domain of Fiber 2 protein provides full protection against fowl adenovirus serotype 4.
    Virus Res. 2023;330:199113.
    PubMed     Abstract available
    
    
    December 2022
14. GALLI C, Pellegrinelli L, Giardina F, Ferrari G, et al
    On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Virus Res. 2022 Dec 26:199033. doi: 10.1016/j.virusres.2022.199033.
    PubMed     Abstract available
    
    
    
15. KOK BH, Lim HT, Lim CP, Lai NS, et al
    Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy.
    Virus Res. 2022;324:199018.
    PubMed     Abstract available
    
    
    October 2022
16. YAN LN, Li D, Wang ZD, Jiang ZZ, et al
    Neutralizing antibodies and T-cell responses to inactivated SARS-Cov-2 vaccine in COVID-19 convalescents one and a half years after infection.
    Virus Res. 2022 Oct 22:198977. doi: 10.1016/j.virusres.2022.198977.
    PubMed     Abstract available
    
    
    
17. HASSNINE AA, Saber MA, Fouad YM, Sarhan H, et al
    Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt.
    Virus Res. 2022 Oct 6:198953. doi: 10.1016/j.virusres.2022.198953.
    PubMed     Abstract available
    
    
    
18. ZHENZHONG W, Chuanxiang Q, Shengqiang G, Jinming L, et al
    Genetic variation and evolution of attenuated African swine fever virus strain isolated in the field: A review.
    Virus Res. 2022;319:198874.
    PubMed     Abstract available
    
    
    September 2022
19. LUO C, Wang Q, Guo R, Zhang J, et al
    A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
    Virus Res. 2022 Sep 26:198937. doi: 10.1016/j.virusres.2022.198937.
    PubMed     Abstract available
    
    
    August 2022
20. HOU LN, Wang FX, Wang YX, Guo H, et al
    Subunit vaccine based on glycoprotein B protects pattern animal guinea pigs from tissue damage caused by infectious bovine rhinotracheitis virus.
    Virus Res. 2022;320:198899.
    PubMed     Abstract available
    
    
    
21. ZHAO Z, Jiang FY, Zhou GQ, Duan HX, et al
    Protective immunity against spring viremia of carp virus by mannose modified chitosan loaded DNA vaccine.
    Virus Res. 2022 Aug 14:198896. doi: 10.1016/j.virusres.2022.198896.
    PubMed     Abstract available
    
    
    July 2022
22. LEGNARDI M, Cecchinato M, Homonnay Z, Dauphin G, et al
    Viral subpopulation variability in different batches of Infectious bronchitis virus (IBV) vaccines based on GI-23 lineage: implications for the field.
    Virus Res. 2022 Jul 21:198877. doi: 10.1016/j.virusres.2022.198877.
    PubMed     Abstract available
    
    
    
23. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    PubMed     Abstract available
    
    
    
24. LI J, Li S, Qiu M, Li X, et al
    Minor and major envelope proteins of PRRSV play synergistic roles in inducing heterologous neutralizing antibodies and conferring cross protection.
    Virus Res. 2022;315:198789.
    PubMed     Abstract available
    
    
    June 2022
25. GONG Y, Sui L, Li Y
    Recombination in Papillomavirus: Controversy and Possibility.
    Virus Res. 2022;314:198756.
    PubMed     Abstract available
    
    
    May 2022
26. JUNG MH, Nikapitiya C, Kim SJ, Han HJ, et al
    Protective immunity induced by ankyrin repeat-containing protein-based DNA vaccine against rock bream iridovirus (RBIV) in rock bream (Oplegnathus fasciatus).
    Virus Res. 2022 May 26:198827. doi: 10.1016/j.virusres.2022.198827.
    PubMed     Abstract available
    
    
    
27. ROWLAND RRR, Doerksen T, Lu A, Sheahan M, et al
    Effect of the host genotype at a Porcine Reproductive and Respiratory Syndrome (PRRS) resistance marker on evolution of the modified-live PRRS vaccine virus in pigs.
    Virus Res. 2022;316:198809.
    PubMed     Abstract available
    
    
    April 2022
28. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
    Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
    Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
    PubMed     Abstract available
    
    
    
29. WEI N, Wang Q, Lin Z, Xu L, et al
    Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
    Virus Res. 2022;312:198711.
    PubMed     Abstract available
    
    
    March 2022
30. SILVA LMN, Santos MR, Carvalho JA, Carvalho OV, et al
    Molecular analysis of the full-length VP2 gene of Brazilian strains of canine parvovirus 2 shows genetic and structural variability between wild and vaccine strains.
    Virus Res. 2022 Mar 12:198746. doi: 10.1016/j.virusres.2022.198746.
    PubMed     Abstract available
    
    
    
31. XU M, Zhang C, Liu Y, Chen S, et al
    A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
    Virus Res. 2022 Mar 7:198740. doi: 10.1016/j.virusres.2022.198740.
    PubMed     Abstract available
    
    
    
32. AGBLA JM, Esona MD, Jaimes J, Gautam R, et al
    Whole genome analysis of rotavirus strains circulating in Benin before vaccine introduction, 2016-2018.
    Virus Res. 2022 Mar 2:198715. doi: 10.1016/j.virusres.2022.198715.
    PubMed     Abstract available
    
    
    January 2022
33. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    PubMed     Abstract available
    
    
    November 2021
34. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    PubMed     Abstract available
    
    
    
35. SUN Y, Li C, Li Z, Shangguan A, et al
    Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo.
    Virus Res. 2021;305:198556.
    PubMed     Abstract available
    
    
    
36. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    PubMed     Abstract available
    
    
    September 2021
37. LEI H, Li S, Lu X, Ren Y, et al
    Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp.
    Virus Res. 2021;302:198467.
    PubMed     Abstract available
    
    
    June 2021
38. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    PubMed     Abstract available
    
    
    May 2021
39. BIDART J, Mignaqui A, Kornuta C, Lupi G, et al
    FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Virus Res. 2021;297:198339.
    PubMed     Abstract available
    
    
    April 2021
40. YAN Z, Chen M, Tang D, Wu X, et al
    Better immune efficacy triggered by the inactivated gI/gE-deleted pseudorabies virus with the additional insertion of gC gene in mice and weaned pigs.
    Virus Res. 2021;296:198353.
    PubMed     Abstract available
    
    
    
41. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available
    
    
    
42. KANAI Y, Kobayashi T
    Rotavirus reverse genetics systems: Development and application.
    Virus Res. 2021;295:198296.
    PubMed     Abstract available
    
    
    March 2021
43. FEARON SH, Dennis SJ, Hitzeroth II, Rybicki EP, et al
    Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Virus Res. 2021;294:198284.
    PubMed     Abstract available
    
    
    
44. KOTAKI T, Yamanaka A, Konishi E, Kameoka M, et al
    A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N
    Virus Res. 2021;294:198278.
    PubMed     Abstract available
    
    
    January 2021
45. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.